Elutia(ELUT) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Elutia Analyst Ratings
Benzinga11:08 ET · Ratings
Cantor Fitzgerald Maintains Elutia(ELUT.US) With Buy Rating, Cuts Target Price to $8
Moomoo NewsMar 7 09:33 ET · Ratings
Elutia Inc. Reports Strong Demand for EluPro
TipRanksMar 6 22:59 ET
Earnings Call Summary | Elutia(ELUT.US) Q4 2024 Earnings Conference
moomoo AIMar 6 18:28 ET · Conference Call
Elutia Inc. Q4 Loss Decreases
RTTNewsMar 6 17:28 ET
Elutia Q4 GAAP EPS $(0.26) Misses $(0.25) Estimate, Sales $5.47M Miss $5.90M Estimate
BenzingaMar 6 16:18 ET

Comments

Trytosaveabit

Feb 3 05:34

update

$Elutia (ELUT.US)$ Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company") today announced it has entered into a definitive agreement with investors for the purchase and sale of 5,520,000 shares of the Company's Class A common stock at a purchase price of $2.50 per share and 480,000 prefunded warrants to purchase up to 480,000 shares of the Company's Class A common stock at a purchase price of $2.499 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately...

Jaguar8

Jan 14 07:08

NEWS

$Elutia (ELUT.US)$
Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand
Tuesday, 14th January at 8:00 am
First FDA-Cleared Antibiotic-Eluting BioEnvelope Now Available in U.S. for Implantable Pacemakers, Defibrillators, and Neurostimulators
SILVER SPRING, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (NASDAQ: ELUT), a pioneer in drug-eluting biomatrix technologies, announced the U.S. commercial launch of EluPro™, the first and only FDA-cleared antibiotic-eluting biom...

1

Rafey Jan

Sep 5, 2024 16:09

$Elutia (ELUT.US)$
@Team moomoo
Why is there a halt in trading?

3

Jaguar8

Sep 5, 2024 15:32

Hey you! Why aren’t you open?🤣

$Elutia (ELUT.US)$

1

Jaguar8

Sep 5, 2024 15:05

NEWS

$Elutia (ELUT.US)$
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
Elutia Inc. (Nasdaq: ELUT) has announced the first patient implant of EluPro™, the world's first FDA-cleared antibiotic-eluting biologic envelope for cardiac pacemakers and neurostimulators.
The procedure was performed by Dr. John Catanzaro at East Carolina University Health Medical Center. EluPro is designed to prevent post-operative co...

2

ELUT Elutia

Trade Overview

Capital Trend

News

Comments

Trending Stocks